• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Benralizumab as initial treatment for chronic eosinophilic pneumonia.

作者信息

Yazawa Shusuke, Toyoshima Mikio, Koda Keigo, Suda Takafumi

机构信息

Department of Respiratory Medicine, Hamamatsu Rosai Hospital, Hamamatsu, Japan.

Department of Respiratory Medicine, Hamamatsu Rosai Hospital, Hamamatsu, Japan.

出版信息

Allergol Int. 2021 Jan;70(1):140-142. doi: 10.1016/j.alit.2020.07.005. Epub 2020 Aug 14.

DOI:10.1016/j.alit.2020.07.005
PMID:32807690
Abstract
摘要

相似文献

1
Benralizumab as initial treatment for chronic eosinophilic pneumonia.贝那利珠单抗作为慢性嗜酸性粒细胞性肺炎的初始治疗药物。
Allergol Int. 2021 Jan;70(1):140-142. doi: 10.1016/j.alit.2020.07.005. Epub 2020 Aug 14.
2
A case of chronic eosinophilic pneumonia successfully treated with mepolizumab.1例用美泊利单抗成功治疗的慢性嗜酸性粒细胞性肺炎病例。
J Allergy Clin Immunol Pract. 2018 Sep-Oct;6(5):1746-1748.e1. doi: 10.1016/j.jaip.2018.06.017. Epub 2018 Jul 7.
3
Relapsing chronic eosinophilic pneumonia treated successfully with benralizumab.使用贝那利珠单抗成功治疗复发性慢性嗜酸性粒细胞性肺炎。
Ann Allergy Asthma Immunol. 2021 Jun;126(6):726-727. doi: 10.1016/j.anai.2021.02.016. Epub 2021 Feb 24.
4
Promising Effects of Benralizumab on Chronic Eosinophilic Pneumonia.贝那利珠单抗对慢性嗜酸性粒细胞性肺炎的显著疗效。
Intern Med. 2020 May 1;59(9):1195-1198. doi: 10.2169/internalmedicine.3606-19. Epub 2020 Feb 1.
5
Long-Term Treatment With Anti-Interleukin 5 Antibodies in a Patient with Chronic Eosinophilic Pneumonia.一名慢性嗜酸性粒细胞性肺炎患者接受抗白细胞介素5抗体的长期治疗
J Investig Allergol Clin Immunol. 2020 Apr 24;30(2):154-155. doi: 10.18176/jiaci.0468. Epub 2019 Nov 28.
6
Benralizumab efficacy by atopy status and serum immunoglobulin E for patients with severe, uncontrolled asthma.针对伴有血清免疫球蛋白 E 升高的重症、未控制哮喘患者，按变应原状态评估 benralizumab 的疗效。
Ann Allergy Asthma Immunol. 2018 May;120(5):504-511.e4. doi: 10.1016/j.anai.2018.01.030. Epub 2018 Feb 1.
7
Severe uncontrolled eosinophilic asthma, which responded to benralizumab after failure to respond to mepolizumab.严重的未控制的嗜酸性粒细胞性哮喘，在对美泊利珠单抗治疗无效后对贝那利珠单抗有反应。
Ann Allergy Asthma Immunol. 2019 Apr;122(4):431-433. doi: 10.1016/j.anai.2018.12.014. Epub 2018 Dec 19.
8
Adherence to inhaled corticosteroids and clinical outcomes following a year of benralizumab therapy for severe eosinophilic asthma.接受苯达莫单抗治疗一年的重度嗜酸性粒细胞性哮喘患者吸入性糖皮质激素的依从性及临床结局
Allergy. 2021 Jul;76(7):2238-2241. doi: 10.1111/all.14737. Epub 2021 Jan 26.
9
Mepolizumab in the treatment of severe eosinophilic asthma: Results from a physician in the field.美泊利珠单抗治疗重度嗜酸性粒细胞性哮喘：一位临床医生的治疗结果
Ann Allergy Asthma Immunol. 2018 Jul;121(1):121-123. doi: 10.1016/j.anai.2018.04.016. Epub 2018 Apr 21.
10
Modulation of blood inflammatory markers by benralizumab in patients with eosinophilic airway diseases.贝那利珠单抗对嗜酸性气道疾病患者血液炎症标志物的调节作用。
Respir Res. 2019 Jan 18;20(1):14. doi: 10.1186/s12931-018-0968-8.

引用本文的文献

1
Feasibility of continued treatment with dupilumab in patients with type 2 inflammatory disease who developed eosinophilic pneumonia: 3 case reports.2型炎症性疾病患者发生嗜酸性粒细胞性肺炎后继续使用度普利尤单抗治疗的可行性：3例病例报告
Respirol Case Rep. 2024 Jun 13;12(6):e01412. doi: 10.1002/rcr2.1412. eCollection 2024 Jun.
2
Monoclonal antibodies in idiopathic chronic eosinophilic pneumonia: a scoping review.特发性慢性嗜酸性粒细胞肺炎中的单克隆抗体：范围综述。
BMC Pulm Med. 2024 Feb 8;24(1):74. doi: 10.1186/s12890-024-02868-3.
3
[Chronic Eosinophilic Pneumonia and New Biological Therapies].
[慢性嗜酸性粒细胞性肺炎与新型生物疗法]
Open Respir Arch. 2021 Jul 26;3(4):100118. doi: 10.1016/j.opresp.2021.100118. eCollection 2021 Oct-Dec.
4
Siglecs as potential targets of therapy in human mast cell- and/or eosinophil-associated diseases.Siglecs 作为人类肥大细胞和/或嗜酸性粒细胞相关疾病治疗的潜在靶点。
Semin Immunol. 2023 Sep;69:101799. doi: 10.1016/j.smim.2023.101799. Epub 2023 Jul 4.
5
Molecular targets for cystic fibrosis and therapeutic potential of monoclonal antibodies.囊性纤维化的分子靶点及单克隆抗体的治疗潜力
Saudi Pharm J. 2022 Dec;30(12):1736-1747. doi: 10.1016/j.jsps.2022.10.002. Epub 2022 Oct 8.
6
Two years follow-up of relapsing eosinophilic pneumonia with concomitant severe asthma successfully treated with benralizumab: A case report and brief review of the literature.倍利珠单抗成功治疗伴严重哮喘的复发性嗜酸性粒细胞性肺炎两年随访：病例报告及文献简要回顾
Respir Med Case Rep. 2022 Dec 13;41:101795. doi: 10.1016/j.rmcr.2022.101795. eCollection 2023.
7
Successful treatment of acute relapse of chronic eosinophilic pneumonia with benralizumab and without corticosteroids: A case report.使用贝那利珠单抗且未使用皮质类固醇成功治疗慢性嗜酸性粒细胞性肺炎急性复发：一例报告
World J Clin Cases. 2022 Jun 26;10(18):6105-6109. doi: 10.12998/wjcc.v10.i18.6105.
8
Lessons learned from targeting eosinophils in human disease.从靶向人类疾病中的嗜酸性粒细胞中吸取的经验教训。
Semin Immunopathol. 2021 Jun;43(3):459-475. doi: 10.1007/s00281-021-00849-w. Epub 2021 Apr 23.